Aligos Therapeutics, Inc.(ALGS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALGS Aligos Therapeutics, Inc.

休市中 09-18 16:00:00 EDT

5.24

+0.07

+1.35%

盘后5.24

+0.000.00%

19:30 EDT

最高5.25	最低5.02	成交量2.13万
今开5.15	昨收5.17	日振幅4.55%
总市值3,272万	流通市值1,940万	总股本624.46万
成交额10.99万	换手率0.58%	流通股本370.27万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALGS","market":"US","secType":"STK","nameCN":"Aligos Therapeutics, Inc.","latestPrice":5.24,"timestamp":1789761600000,"preClose":5.17,"halted":0,"volume":21340,"hourTrading":{"tag":"盘后","latestPrice":5.24,"preClose":5.24,"latestTime":"19:30 EDT","volume":354,"amount":1855.842,"timestamp":1789774207077,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.013539651837524234,"floatShares":3702700,"shares":6244600,"eps":-7.301555,"marketStatus":"休市中","change":0.07,"latestTime":"09-18 16:00:00 EDT","open":5.15,"high":5.25,"low":5.015,"amount":109898.95136,"amplitude":0.045455,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.301555,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"listingDate":1602820800000,"exchange":"NASDAQ","adjPreClose":5.17,"preHourTrading":{"tag":"盘前","latestPrice":5,"preClose":5.17,"latestTime":"04:00 EDT","volume":1,"amount":5,"timestamp":1789718405751,"change":-0.17,"changeRate":-0.032882,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":5.24,"preClose":5.24,"latestTime":"19:30 EDT","volume":354,"amount":1855.842,"timestamp":1789774207077,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6549749265546367,"impliedVol":0.1576,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ALGS","defaultTab":"news","newsList":[{"id":"1171371738","title":"Aligos Therapeutics宣布：合作伙伴Amoytop在中国启动潜在同类最佳反义寡核苷酸Alg-170675的1期临床首例受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1171371738","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171371738?lang=zh_cn&edition=full","pubTime":"2026-08-13 04:06","pubTimestamp":1786565174,"startTime":"0","endTime":"0","summary":"Aligos Therapeutics, Inc.（ALGS）今日宣布，其合作伙伴Amoytop已在中国完成了潜在同类最佳反义寡核苷酸Alg-170675的1期临床研究首例受试者给药。这一里程碑标志着该候选药物正式进入人体试验阶段，为后续开发铺平了道路。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALGS","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105092086","title":"Aligos Therapeutics获2500万美元首付款，源于大中华区慢性乙型肝炎病毒药物独家许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1105092086","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105092086?lang=zh_cn&edition=full","pubTime":"2026-07-07 04:06","pubTimestamp":1783368416,"startTime":"0","endTime":"0","summary":"专注于慢性乙型肝炎病毒（HBV）感染治疗的生物技术公司Aligos Therapeutics, Inc.，近日宣布已收到一笔高达2500万美元的首付款。这笔款项源自其与合作伙伴就创新药物Pevifoscorvir Sodium（一款针对慢性HBV感染的候选药物）在大中华区达成的独家许可协议。该协议标志着Aligos Therapeutics在拓展关键亚洲市场方面迈出了重要一步，有望为众多慢性乙肝患者带来新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","ALGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174430401","title":"Aligos Therapeutics Inc 将获2500万美元首付款及最高4.2亿美元里程碑款项加分层特许权使用费","url":"https://stock-news.laohu8.com/highlight/detail?id=1174430401","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174430401?lang=zh_cn&edition=full","pubTime":"2026-04-16 18:04","pubTimestamp":1776333864,"startTime":"0","endTime":"0","summary":"生物制药公司Aligos Therapeutics Inc（ALGS）宣布达成一项重大合作协议，公司将获得2500万美元的预付款。根据协议条款，未来还有望获得总额最高达4.2亿美元的里程碑付款，并附加分层结构的特许权使用费安排。\n这笔交易凸显了市场对Aligos Therapeutics研发管线的认可。分层特许权使用费机制意味着公司未来收益将与产品商业化表现直接挂钩，随着销售额增长， royalty 比例将逐步提升。\n此次合作将为Aligos Therapeutics提供重要资金支持，加速其创新疗法的研发进程。里程碑付款将分阶段触发，与研发进展和监管审批等关键节点紧密关联。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALGS","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137271619","title":"Aligos Therapeutics与厦门安普拓生物签署独家许可协议 共同开发大中华区慢性乙肝药物Pevifoscorvir Sodium","url":"https://stock-news.laohu8.com/highlight/detail?id=1137271619","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137271619?lang=zh_cn&edition=full","pubTime":"2026-04-16 18:02","pubTimestamp":1776333736,"startTime":"0","endTime":"0","summary":"Aligos Therapeutics, Inc.  宣布与厦门安普拓生物技术有限公司达成独家授权合作，双方将共同在大中华区推进抗慢性乙型肝炎病毒药物Pevifoscorvir Sodium的研发及商业化进程。根据协议条款，Aligos公司将授予厦门安普拓生物在大中华区域开发、生产和销售Pevifoscorvir Sodium的独家权利。Pevifoscorvir Sodium作为一种新型抗病毒候选药物，其临床试验数据已显示出对慢性乙肝病毒感染的潜在治疗价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","ALGS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142444630","title":"Aligos Therapeutics公司：数据安全监测委员会建议扩大样本规模继续研究；未达无效性标准","url":"https://stock-news.laohu8.com/highlight/detail?id=1142444630","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142444630?lang=zh_cn&edition=full","pubTime":"2026-04-15 04:06","pubTimestamp":1776197218,"startTime":"0","endTime":"0","summary":"生物制药公司Aligos Therapeutics, Inc.近日宣布，其独立数据安全监测委员会在对临床试验数据进行审阅后，建议研究在扩大样本量的情况下继续进行。委员会确认，当前研究数据未达到预设的无效性标准，这表明试验药物可能展现出令人鼓舞的治疗潜力。\n该建议意味着研究将按计划推进，同时招募更多受试者以增强数据的统计效力。这一决定通常被视为药物研发过程中的积极信号，反映出监管方对试验安全性与初步有效性的认可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","ALGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178710053","title":"Aligos Therapeutics Inc获得FDA针对慢性乙肝药物Pevifoscorvir Sodium的快速通道资格认定","url":"https://stock-news.laohu8.com/highlight/detail?id=1178710053","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178710053?lang=zh_cn&edition=full","pubTime":"2026-04-15 04:06","pubTimestamp":1776197179,"startTime":"0","endTime":"0","summary":"Aligos Therapeutics Inc（股票代码：ALGS）宣布，其研发的慢性乙型肝炎治疗药物Pevifoscorvir Sodium已获得美国食品药品监督管理局（FDA）授予的快速通道资格认定。这一认定将加速该药物的审评进程，有望为慢性乙肝患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALGS","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518220020","title":"Aligos Therapeutics, Inc.盘中异动 早盘急速下挫7.26%报12.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518220020?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:34","pubTimestamp":1741613645,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时34分，Aligos Therapeutics, Inc.股票出现异动，股价快速下挫7.26%。截至发稿，该股报12.00美元/股，成交量2.7267万股，换手率0.76%，振幅3.79%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2096.04%、413.43%、64.56%，振幅较大的相关个股有Akero Therapeutics, Inc.、Xencor, Inc.、Seer, Inc.，振幅分别为100.05%、99.13%、98.72%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213405a26a25ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213405a26a25ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","ALGS","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169357471","title":"Aligos Therapeutics 第四季度每股收益 $(13.08) 未达预期，销售额 $629.00 千美元 超出预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1169357471","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169357471?lang=zh_cn&edition=full","pubTime":"2025-03-10 20:06","pubTimestamp":1741608360,"startTime":"0","endTime":"0","summary":"Aligos Therapeutics报告季度每股亏损 $，比分析师的共识预期 $ 差 468.7%。公司报告季度销售额为 62.9 万美元，超出分析师共识预期的 43.33 万美元 45.15%。与去年同期销售额 201 万美元相比，这一数据下降了 68.69%。以上内容来自Benzinga Earnings专栏，原文如下：Aligos $Therapeutics$  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 468.7 percent. This is a 137.82 percent decrease over losses of $ per share from the same period last year.  The company reported quarterly sales of $629.00 thousand which beat the analyst consensus estimate of $433.33 t","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALGS","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517166112","title":"Aligos Therapeutics, Inc.盘中异动 早盘股价大跌5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517166112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517166112?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:38","pubTimestamp":1741271907,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时38分，Aligos Therapeutics, Inc.股票出现波动，股价急速下跌5.48%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。其相关个股中，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1107.94%、213.59%、54.76%，振幅较大的相关个股有Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为31.46%、30.53%、23.12%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223828963c4e92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223828963c4e92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","ALGS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516065196","title":"Aligos Therapeutics, Inc.盘中异动 股价大跌5.02%报16.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516065196","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516065196?lang=zh_cn&edition=full","pubTime":"2025-03-04 01:52","pubTimestamp":1741024325,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日01时52分，Aligos Therapeutics, Inc.股票出现异动，股价大幅下跌5.02%。截至发稿，该股报16.02美元/股，成交量4.3923万股，换手率1.22%，振幅6.70%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Alto Neuroscience, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为4294.62%、178.37%、175.13%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040152059637da79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040152059637da79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","LENZ","ALGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514096332","title":"Aligos Therapeutics, Inc.盘中异动 下午盘大幅下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514096332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514096332?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:28","pubTimestamp":1740688132,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时28分，Aligos Therapeutics, Inc.股票出现异动，股价急速跳水5.07%。截至发稿，该股报16.85美元/股，成交量14.2729万股，换手率3.98%，振幅9.46%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Xortx Therapeutics Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1927.83%、378.45%、194.99%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228042852a256c99e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228042852a256c99e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4505","ALGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514856875","title":"Aligos Therapeutics, Inc.盘中异动 急速拉升5.31%报18.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514856875?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:34","pubTimestamp":1740580495,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时34分，Aligos Therapeutics, Inc.股票出现异动，股价快速上涨5.31%。截至发稿，该股报18.25美元/股，成交量8681股，换手率0.24%，振幅4.53%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Channel Therapeutics Corporation、Immunoprecise Antibodies Ltd.涨幅较大，Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.、Immunoprecise Antibodies Ltd.较为活跃，换手率分别为127.32%、94.89%、76.22%，振幅较大的相关个股有Humacyte Inc C/Wts 27/08/2026 、Nutriband Inc C/Wts 、Channel Therapeutics Corporation，振幅分别为38.41%、17.13%、16.86%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262234569893ab69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262234569893ab69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALGS","BK4139","BK4505","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514399090","title":"Aligos Therapeutics, Inc.盘中异动 股价大跌6.51%报16.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514399090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514399090?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:37","pubTimestamp":1740494235,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时37分，Aligos Therapeutics, Inc.股票出现异动，股价大幅下挫6.51%。截至发稿，该股报16.66美元/股，成交量8885股，换手率0.25%，振幅3.42%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Gt Biopharma, Inc.涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为793.45%、560.91%、495.53%，振幅较大的相关个股有Organovo Holdings, Inc.、Gt Biopharma, Inc.、Adial Pharmaceuticals, Inc，振幅分别为86.72%、26.11%、20.51%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223715a2538882&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223715a2538882&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ALGS","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513904732","title":"Aligos Therapeutics, Inc.盘中异动 股价大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513904732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513904732?lang=zh_cn&edition=full","pubTime":"2025-02-22 00:51","pubTimestamp":1740156706,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日00时51分，Aligos Therapeutics, Inc.股票出现波动，股价大幅下挫5.25%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Osr Holdings, Inc.、Nkgen Biotech, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为231.30%、161.40%、124.05%，振幅较大的相关个股有Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech, Inc.，振幅分别为72.46%、57.50%、48.35%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222005146988dfcd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222005146988dfcd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","ALGS","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512348185","title":"Aligos Therapeutics, Inc.盘中异动 早盘股价大跌5.05%报21.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512348185","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512348185?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:58","pubTimestamp":1739980689,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时58分，Aligos Therapeutics, Inc.股票出现异动，股价急速下跌5.05%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Osr Holdings Inc C/Wts 02/09/2028 、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Solid Biosciences Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为556.97%、241.94%、106.27%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Aditxt, Inc.、Allogene Therapeutics, Inc.，振幅分别为207.68%、48.18%、36.97%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219235809abd5107d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219235809abd5107d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ALGS","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512178196","title":"Aligos Therapeutics, Inc.盘中异动 大幅下挫5.03%报22.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512178196","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512178196?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:19","pubTimestamp":1739906369,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时19分，Aligos Therapeutics, Inc.股票出现异动，股价大幅下挫5.03%。截至发稿，该股报22.48美元/股，成交量9.6674万股，换手率2.69%，振幅7.58%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。其相关个股中，Aditxt, Inc.、Allogene Therapeutics, Inc.、Pulmatrix, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为845.55%、209.84%、168.60%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031930a24ae823&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031930a24ae823&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","ALGS","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512529945","title":"在所有治疗领域强劲业绩的推动下，益普生2024年实现稳健业绩增长并确认2025年全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2512529945","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512529945?lang=zh_cn&edition=full","pubTime":"2025-02-17 17:58","pubTimestamp":1739786280,"startTime":"0","endTime":"0","summary":"本年度还与Skyhawk Therapeutics签署了一项合作协议，开发用于治疗罕见神经系统疾病的RNA调节小分子药物。环境、社会和治理 2024年，益普生采取了重要步骤，以实施可持续发展战略的宏伟目标。经过密集转型项目，目前益普生全球99.8%的电力来自可再生能源。2025年财务指引 益普生为2025财年制定了以下财务指引，其中排除了潜在的后期业务开发交易的任何影响：  以固定汇率计算，总销售额增长超过5.0%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"https://wwwold.prnasia.com/story/archive/4620551_ZH20551_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4620551_ZH20551_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4231","BK4505","IPN","IPSEY","ALGS","BK4139","BK4080","ADC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511973346","title":"Aligos Therapeutics, Inc.盘中异动 急速拉升5.43%报22.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511973346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511973346?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:17","pubTimestamp":1739546241,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时17分，Aligos Therapeutics, Inc.股票出现波动，股价大幅上涨5.43%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Moleculin Biotech, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Cns Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2358.95%、615.56%、469.87%，振幅较大的相关个股有Moleculin Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Cns Pharmaceuticals, Inc.，振幅分别为66.93%、43.67%、40.35%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231722abcf1100&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231722abcf1100&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","ALGS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510204387","title":"Aligos Therapeutics, Inc.盘中异动 早盘股价大跌5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510204387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510204387?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:34","pubTimestamp":1739284445,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时34分，Aligos Therapeutics, Inc.股票出现波动，股价急速跳水5.42%。截至发稿，该股报26.20美元/股，成交量6252股，换手率0.17%，振幅2.17%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.96%。其相关个股中，Lipella Pharmaceuticals Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、In8Bio, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.较为活跃，换手率分别为2013.25%、534.44%、178.65%，振幅较大的相关个股有In8Bio, Inc.、Ocean Biomedical, Inc.、Akari Therapeutics Plc，振幅分别为25.06%、21.89%、16.07%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112234059881bd59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112234059881bd59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","LENZ","ALGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510869362","title":"Aligos Therapeutics, Inc.盘中异动 股价大涨5.67%报29.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510869362","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510869362?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:08","pubTimestamp":1739200110,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时08分，Aligos Therapeutics, Inc.股票出现异动，股价急速拉升5.67%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Biodexa Pharmaceuticals Plc、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2375.57%、1451.34%、906.24%，振幅较大的相关个股有Ocean Biomedical, Inc.、Biodexa Pharmaceuticals Plc、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为69.83%、66.09%、39.57%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210230830a240aac4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210230830a240aac4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALGS","BK4139","BK4505","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aligos.com","stockEarnings":[{"period":"1week","weight":0.0038},{"period":"1month","weight":-0.2395},{"period":"3month","weight":-0.0076},{"period":"6month","weight":-0.2305},{"period":"1year","weight":-0.4755},{"period":"ytd","weight":-0.4378}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0096},{"period":"3month","weight":0.02},{"period":"6month","weight":0.1744},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.117}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aligos Therapeutics, Inc.于2018年2月5日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于开发新疗法，以解决肝病和病毒感染方面未满足的医疗需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.020655},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.084797},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.197646},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.12162},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.029634},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.083851},{"month":7,"riseRate":0.5,"avgChangeRate":-0.019227},{"month":8,"riseRate":0.666667,"avgChangeRate":0.159266},{"month":9,"riseRate":0,"avgChangeRate":-0.139442},{"month":10,"riseRate":0.4,"avgChangeRate":-0.048799},{"month":11,"riseRate":0.666667,"avgChangeRate":0.350449},{"month":12,"riseRate":0.333333,"avgChangeRate":0.114782}],"exchange":"NASDAQ","name":"Aligos Therapeutics, Inc.","nameEN":"Aligos Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aligos Therapeutics, Inc.(ALGS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aligos Therapeutics, Inc.(ALGS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aligos Therapeutics, Inc.,ALGS,Aligos Therapeutics, Inc.股票,Aligos Therapeutics, Inc.股票老虎,Aligos Therapeutics, Inc.股票老虎国际,Aligos Therapeutics, Inc.行情,Aligos Therapeutics, Inc.股票行情,Aligos Therapeutics, Inc.股价,Aligos Therapeutics, Inc.股市,Aligos Therapeutics, Inc.股票价格,Aligos Therapeutics, Inc.股票交易,Aligos Therapeutics, Inc.股票购买,Aligos Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aligos Therapeutics, Inc.(ALGS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aligos Therapeutics, Inc.(ALGS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}